AXR vs CHMI

The company exhibits weak fundamental health with a Piotroski F-Score of 3/9, indicating significant financial distress risks. Despite strong profitability margins and a debt-free balance sheet, the business is experiencing sharp declines in revenue and earnings, with YoY earnings down 70.7%. The stock trades below its Graham Number of $33.48 but at a premium to its growth-adjusted intrinsic value of $13.51, suggesting overvaluation given deteriorating fundamentals. Persistent negative earnings surprises and lack of analyst coverage further undermine confidence.

CHMI exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a critical liquidity crisis evidenced by a current ratio of 0.09. While the stock trades at a discount to book value (P/B 0.73), this is offset by a catastrophic dividend payout ratio of 1100%, indicating the dividend is entirely unsustainable and likely funded by debt or capital erosion. Severe contractions in both YoY revenue (-34.8%) and earnings (-49.5%) suggest a failing business model in the current mortgage environment. The combination of high leverage (Debt/Equity 5.39) and negative growth trends makes this a high-risk speculative play rather than a value investment.